Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
Completed · Phase 3
Conditions studied: Gastroesophageal Reflux
In brief
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.
Key facts
- Study ID
- NCT00300755
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 60
- Starts
- 2006-05-01
- Expected to finish
- 2008-04-01
- Last updated by the study team
- 2010-05-19
Who can join
Age: 1 and older, up to 5. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to undergo endoscopy with required biopsy
- Ages 1 through 5 years
- Endoscopically confirmed GERD by positive endoscopic evidence of reflux related esophagitis or positive histologic evidence of esophagitis consistent with GERD Other inclusions apply.
You may not qualify if…
- History or presence of upper gastrointestinal anatomic or motor disorders
- Known current or active cow's milk allergy
- Malignancy
- Other exclusions apply.
Where it is running
- Study site — Mobile, Alabama, United States
- Study site — Phoenix, Arizona, United States
- Study site — Oakland, California, United States
- Study site — Orange, California, United States
- Study site — Sacramento, California, United States
- Study site — San Diego, California, United States
- Study site — Wilmington, Delaware, United States
- Study site — Washington D.C., District of Columbia, United States
- Study site — Gainesville, Florida, United States
- Study site — Jacksonville, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Orlando, Florida, United States
- Study site — Pensacola, Florida, United States
- Study site — Peoria, Illinois, United States
- Study site — Lexington, Kentucky, United States
- Study site — Louisville, Kentucky, United States
- Study site — Boston, Massachusetts, United States
- Study site — Boston, Massachusetts, United States
- Study site — Flint, Michigan, United States
- Study site — Southfield, Michigan, United States
- Study site — Jackson, Mississippi, United States
- Study site — Omaha, Nebraska, United States
- Study site — Las Vegas, Nevada, United States
- Study site — Egg Harbor, New Jersey, United States
- Study site — Morristown, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.